Single User License
INR 19635
Site License
INR 39270
Corporate User License
INR 58905

Service Tax Additional

select a format

Single User License
USD 300
Site License
USD 600
Corporate User License
USD 900


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Nivalis Therapeutics, Inc. (NVLS)-Financial and Strategic SWOT Analysis Review

Nivalis Therapeutics, Inc. (NVLS)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH220400FSA
  • |
  • Pages: 25
  • |
  • October 2016
  • |
  • |
  Request for Sample Report

This is an on-demand report and will be delivered within 2 working days (excluding weekends) of the purchase.

Executive Summary

Nivalis Therapeutics, Inc. (Nivalis Therapeutics), formerly N30 Pharmaceuticals is a pharmaceutical company that develops a novel class of disease modifying therapies, which can preserve intracellular GSNO in the pathophysiology of cystic fibrosis. The company also carries out the discovery, development and commercialization of s-nitrosothiol drugs. It offers products for the treatment of respiratory and cardiopulmonary diseases such as cystic fibrosis, asthma and chronic obstructive pulmonary disease. Nivalis Therapeutics' N91115 targets patients with the F508del mutation, which is the common disease causing mutation in cystic fibrosis. The company has developed small molecule inhibitors of the S-nitrosoglutathione reductase protein that can increase CFTR activity and decrease airway inflammation. Nivalis Therapeutics is headquartered in Boulder, Colorado, the US.

Nivalis Therapeutics, Inc. Key Recent Developments

Aug 01, 2016: Nivalis Therapeutics Reports Second Quarter 2016 Financial Results

May 02, 2016: Nivalis Therapeutics Reports First Quarter 2016 Financial Results

Apr 18, 2016: Nivalis Therapeutics Appoints David Rodman, MD as Chief Medical Officer and Executive Vice President of Discovery

Feb 29, 2016: Nivalis Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results

Nov 02, 2015: Nivalis Therapeutics Reports Third Quarter and Nine-Month Financial Results for 2015

This comprehensive SWOT profile of Nivalis Therapeutics, Inc. provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Nivalis Therapeutics, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents

Section 1-About the Company

Nivalis Therapeutics, Inc.-Key Information

Nivalis Therapeutics, Inc.-Overview

Nivalis Therapeutics, Inc.-Key Employees

Nivalis Therapeutics, Inc.-Key Employee Biographies

Nivalis Therapeutics, Inc.-Key Operational Heads

Nivalis Therapeutics, Inc.-Major Products and Services

Nivalis Therapeutics, Inc.-History

Nivalis Therapeutics, Inc.-Company Statement

Nivalis Therapeutics, Inc.-Locations And Subsidiaries

Nivalis Therapeutics, Inc.-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Nivalis Therapeutics, Inc.-Business Description

Nivalis Therapeutics, Inc.-Corporate Strategy

Nivalis Therapeutics, Inc.-SWOT Analysis

SWOT Analysis-Overview

Nivalis Therapeutics, Inc.-Strengths

Nivalis Therapeutics, Inc.-Weaknesses

Nivalis Therapeutics, Inc.-Opportunities

Nivalis Therapeutics, Inc.-Threats

Nivalis Therapeutics, Inc.-Key Competitors

Section 3-Company Financial Performance Charts

Nivalis Therapeutics, Inc.-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix



Ratio Definitions

About GlobalData

Contact Us


Note*: Some sections may be missing if data is unavailable for the company

List of Figures

Nivalis Therapeutics, Inc., Performance Chart

Nivalis Therapeutics, Inc., Ratio Charts

List of Tables

Nivalis Therapeutics, Inc., Key Information

Nivalis Therapeutics, Inc., Key Ratios

Nivalis Therapeutics, Inc., Share Data

Nivalis Therapeutics, Inc., Major Products and Services

Nivalis Therapeutics, Inc., History

Nivalis Therapeutics, Inc., Key Employees

Nivalis Therapeutics, Inc., Key Employee Biographies

Nivalis Therapeutics, Inc., Key Operational Heads

Nivalis Therapeutics, Inc., Other Locations

Nivalis Therapeutics, Inc., Subsidiaries

Nivalis Therapeutics, Inc., Key Manufacturing facilities

Nivalis Therapeutics, Inc., Key Competitors

Nivalis Therapeutics, Inc., SWOT Analysis

Nivalis Therapeutics, Inc., Ratios based on current share price

Nivalis Therapeutics, Inc., Annual Ratios

Nivalis Therapeutics, Inc., Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

This is an on-demand report and will be delivered within 2 working days (excluding weekends) of the purchase.

To know more information on Purchase by Section, please send a mail to query [@]

Nivalis Therapeutics, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]